Insider trades

Geary Richard S., Chief Officer of Ionis Pharmaceuticals IONS, has filed 0 purchases and 28 sales on the open market. Over the past 12 months that comes to a net sale of $9.6M. The latest trade was on 25/11/06.

Geary Richard S.

EVP, Chief Development Officer
First filing
23/03/02
Trades
82 trades
Buys / sales
0 / 28
12-month net buying
−$9.6M
Last trade
25/11/06

Trading activity

Transactions

Trade type
IONS
Open-market sale10b5-1 plan · Amendment25/11/03–25/11/0625/11/0736,319 sh6 trades$75.66avg.$2,747,922.81−37.8%
IONS
Open-market sale10b5-1 plan25/10/31–25/11/0325/11/0390,929 sh5 trades$75.11avg.$6,829,576.39−60.4%
Open-market sale10b5-1 plan25/09/3025/10/0157,900 sh$65.24$3,777,396−42.1%
Open-market sale10b5-1 plan25/09/0225/09/0410,000 sh$50.37$503,700−11.2%
Open-market sale10b5-1 plan25/08/0525/08/0610,000 sh$42.86$428,600−10.1%
Open-market sale25/01/3125/02/031,406 sh$32.40$45,554.4−1.4%
Open-market sale25/01/1625/01/177,072 sh$32.86$232,385.92−6.8%
Open-market saleAmendment24/02/0224/09/041,995 sh$50.04$99,829.8−2.2%
IONS
Open-market sale10b5-1 plan24/08/28–24/08/2924/09/03651 sh2 trades$49.40avg.$32,158.73−0.8%
Open-market sale10b5-1 plan24/08/0524/08/062,430 sh$48.00$116,640−2.8%
Open-market sale24/02/0224/02/021,961 sh$50.04$98,128.44−2.2%
Open-market sale24/01/1724/01/187,338 sh$50.42$369,981.96−7.9%
IONS
Open-market sale10b5-1 plan23/12/20–23/12/2123/12/2210,612 sh2 trades$49.50avg.$525,340.48−12.7%
IONS
Open-market sale10b5-1 plan23/12/1423/12/1810,613 sh2 trades$49.58avg.$526,226.89−12.7%
Open-market sale23/02/0623/02/071,920 sh$40.66$78,067.2−2.6%
Open-market sale23/01/1823/01/197,873 sh$39.57$311,534.61−10.0%